Mereo BioPharma MREO
NASDAQ MREO
$0.31 +0.01 (+2.92%)
At close: Nov 11, 2026 · 4:00 PM EST

Mereo BioPharma (MREO) Operating Margin (2023 - 2026)

Updated

Mereo BioPharma's Operating Margin came in at -8021.40% for FY2025.

Analysis

Mereo BioPharma (MREO) Operating Margin (2023 - 2026) Analysis & Trends

  • Operating Margin carries a four-year change of -7963.98 percentage points (FY2021 to FY2025).
  • Per Business Quant, earlier years put Operating Margin at -284.16% in FY2023 and -57.42% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Mereo BioPharma 47.91 Mn -79.40 Mn 800,000.00 -777.25%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -777.25%
Mar 31, 2026 -79,690.91%
Jun 30, 2025 -2,099.80%
Dec 31, 2023 -712.80%
Jun 30, 2023 -9.01%
API Access

Mereo BioPharma Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=MREO&period=max&api_key=YOUR_API_KEY